Latest California Healthline Stories
Watch: Defining The Debate On Health Care Coverage Options
Politicians are throwing around a lot of terms when they talk about their health care plans: universal care, “Medicare for All,” “Medicare Buy-In.” KHN helps explain what they are talking about.
Trump Administration Hits Brakes On Law To Curb Unneeded Medicare CT Scans, MRIs
Critics worry the delays come at a steep cost: Medicare paying for millions of unnecessary exams and patients subject to radiation for no medical benefit.
Going Down Fighting: Dying Activist Champions ‘Medicare For All’
Presidential hopeful Elizabeth Warren tried to tell the story of Ady Barkan in the latest Democratic debate. He’s one of the most prominent advocates for “Medicare for All” and is spending his remaining time alive doing everything he can to make the case that all Americans need affordable health coverage.
Class-Action Lawsuit Seeks To Let Medicare Patients Appeal Gap in Nursing Home Coverage
Medicare beneficiaries under observation care in the hospital can face higher costs for treatment and are not covered for nursing home care when discharged. A federal trial in Hartford, Conn., will determine whether the government’s ban on appeals involving observation care coverage is fair.
To Save Money, American Patients And Surgeons Meet In Cancun
The patient is from Mississippi. The surgeon is from Wisconsin. They meet in a Mexican resort for knee replacement surgery. Because the care costs so much less than in the U.S, the patient’s health plan pays her $5,000.
Where Tourism Brings Pricey Health Care, Locals Fight Back
Residents in Colorado ski resort country found relief from high insurance premiums and high hospital costs by joining forces and negotiating prices directly with the local hospital.
KHN’s ‘What The Health?’: Gun Violence And The Politics Of Public Health
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
The drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive.
Federal Experts’ Advice On HPV Vaccine Could Leave Adults Confused
A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. But some public health advocates worry that the advice doesn’t provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine.
Doctors Argue Plans To Remedy Surprise Medical Bills Will ‘Shred’ The Safety Net
A case of questionable logic.